Ban & Monetization Policy
MyLiveRoom Rewards Program Rules & Eligibility
23-Valent Pneumococcal Vaccine Market Analysis 2034 | Regional Trends
According to a newly published market research report by 24LifeSciences, global 23-valent pneumococcal polysaccharide vaccine market was valued at USD 1012 million in 2023 and is projected to reach USD 2083 million by 2030, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period from 2024 to 2030.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3857/valent-pneumococcal-polysaccharide-vaccine--global-outlook-and-market
According to a newly published market research report by 24LifeSciences, global 23-valent pneumococcal polysaccharide vaccine market was valued at USD 1012 million in 2023 and is projected to reach USD 2083 million by 2030, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period from 2024 to 2030.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3857/valent-pneumococcal-polysaccharide-vaccine--global-outlook-and-market
23-Valent Pneumococcal Vaccine Market Analysis 2034 | Regional Trends
According to a newly published market research report by 24LifeSciences, global 23-valent pneumococcal polysaccharide vaccine market was valued at USD 1012 million in 2023 and is projected to reach USD 2083 million by 2030, growing at a compound annual growth rate (CAGR) of 11.1% during the forecast period from 2024 to 2030.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3857/valent-pneumococcal-polysaccharide-vaccine--global-outlook-and-market
0 Yorumlar
0 hisse senetleri
40 Views
0 önizleme
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
